Don’t Miss TipRanks’ Half-Year Sale
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
Arcellx Inc ( (ACLX) ) just unveiled an update.
Arcellx Inc. held its Annual Meeting of Stockholders on May 28, 2025, where approximately 96.15% of the outstanding shares were represented. During the meeting, three Class III directors were elected, the executive compensation was approved on an advisory basis, and the appointment of PricewaterhouseCoopers LLP as the independent registered accounting firm for the fiscal year ending December 31, 2025, was ratified.
The most recent analyst rating on (ACLX) stock is a Buy with a $85.00 price target. To see the full list of analyst forecasts on Arcellx Inc stock, see the ACLX Stock Forecast page.
Spark’s Take on ACLX Stock
According to Spark, TipRanks’ AI Analyst, ACLX is a Neutral.
Arcellx Inc’s stock score reflects a mix of financial challenges and promising corporate developments. While financial performance and valuation are pressured by ongoing losses, positive clinical trial results and strategic board changes offer potential upside. Technical signals suggest a neutral market sentiment.
To see Spark’s full report on ACLX stock, click here.
More about Arcellx Inc
Average Trading Volume: 799,273
Technical Sentiment Signal: Sell
Current Market Cap: $3.41B
See more data about ACLX stock on TipRanks’ Stock Analysis page.